Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emission computed tomography

Giornale Italiano di Cardiologia

Volumn 27, Issue 11, 1997, Pages 1181-1186

  Bax, Jeroen J ^a   Valkema, Roelf ^b   Visser, Frans C ^c   Poldermans, Don ^b   Cornel, Jan H ^d   Van Lingen, Arthur ^c   Krenning, Eric P ^b   Rambaldi, Riccardo ^b   Roelandt, Jos R T C ^b   Visser, Cees A ^c   Fioretti, Paolo M ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Thoraxcenter Erasmus Medical Center   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Location Alkmaar   (Netherlands)

^e SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Positron emission tomography; Viable myocardium

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; THALLIUM 201;

DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EDITORIAL; EXERCISE TEST; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOTONIC AGENTS; DOBUTAMINE; FLUORODEOXYGLUCOSE F18; HUMANS; MYOCARDIUM; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 9844240507     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (42)

1. GHALI JK, COOPER RS, FORD E: Trends in hospitalization rates for heart failure in the United States, 1973-1986. Arch Intern Med 1990; 150: 769-773.
2. EMOND M, MOCK MB, DAVIS KB, ET AL: Long-term survival of medically-treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1994; 90: 2645-2657.
3. Ho KKL, ANDERSON KM, KANNEL WB, GROSSMAN W, LEVY D: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115.
4. PIGOTT JD, KOUCHOUKOS NT, OBERMAN A, CUTTER GR: Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985; 5: 1036-1045.
5. COHN JN: The management of chronic heart failure. N Engl J Med 1996; 335: 490-498.
6. PACKER M, BRISTOW MR, COHN JN ET AL: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
7. LOUIE HW, LAKS H, MILGALTER E, ET AL: Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991; 84 (Suppl III): 290-295.
8. ELEFTERIADES JA, TOLIS G, LEVI E, MILLS LK, ZARET BL: Coronary artery by-pass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22: 1411-1417.
9. KENNEDY JW, KAISER GC, FISHER LD, ET AL: Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation 1981; 63: 793-802.
10. MARSHALL RC, TILLISCH JH, PHELPS ME, ET AL: Identificatión and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67: 766-778.
11. BRUNKEN R, TILLISCH J, SCHWAIGER M, ET AL: Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic q wave infarctions: evidence for persistence of viable tissue in some infarct regions by position emission tomography. Circulation 1986; 73: 951-963.
12. TILLISCH J, BRUNKEN R, MARSHALL R, ET AL: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
13. DILSIZIAN V, ROCCO TP, FREEDMAN NM, LEON MB, BONOW RO: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
14. MAES AF, BORGERS M, FLAMENG W, ET AL: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997; 29: 62-68.
15. ARNESE M, CORNEL JH, SALUSTRI A, ET AL: Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201-TI SPECT. Circulation 1995; 91: 2748-2752.
16. VAN LINGEN A, HUIJGENS PC, VISSER FC, ET AL: Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992; 19: 315-321.
17. STOLL HP, HELLWIG N, ALEXANDER C, OEZBEK C, SCHIEFFER H, OBERHAUSEN E: Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography. Eur J Nucl Med 1994; 21: 1085-1093.
18. SANDLER MP, VIDELEFSKY S, DELBEKE D, ET AL: Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 864-869.
19. PHELPS ME, HUFFMAN EJ, SELIN C, ET AL: Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 1978; 19: 1311-1319.
20. SCHELBERT HR: Metabolic imaging to assess myocardial viability. J Nucl Med 1994; 35 (Suppl): 8-14.
21. MADDAHI J, SCHELBERT H, BRUNKEN R, DI CARLI M: Role of TI-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994; 35: 707-715.
22. BONOW RO: Identification of viable myocardium. Circulation 1996; 94: 2674-2680.
23. MAES A, FLAMENG W, NUYTS J, ET AL: Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994; 90: 735-745.
24. EITZMAN D, AL-AOUAR ZR, KANTER HL, ET AL: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
25. DI CARLI M, DAVIDSON M, LITTLE R, ET AL: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
26. LEE KS, MARWICK TH, COOK SA, ET AL: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994; 90: 2687-2694.
27. TAMAKI N, KAWAMOTO M, TAKAHASHI N, ET AL: Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22: 1621-1627.
28. YOSHIDA K, GOULD KL: Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993; 22: 984-987.
29. BERGMANN SR, HERRERO P, MARKHAM J, WEINHEIMER CJ, WALSH MN: Noninvasive quantification of myocardial blood flow in human subjects with 015-labeled water and positron emission tomography. J Am Coll Cardiol 1989; 14: 639-652.
30. 18F-fluorodeoxyglucose using single photon emission computed tomography. Eur Heart J 1993; 14: 1675-1682.
31. 18F-fluorodeoxyglucose imaged with positron emission tomography and single photon emission computed tomography in dyssynergic myocardium. J Nucl Med 1996; 37: 1631-1636.
32. BURT RW, PERKINS OW, OPPENHEIM BE, ET AL: Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for the detection of myocardial viability. J Nucl Med 1995; 36: 176-179.
33. VALKEMA R, POLDERMANS D, REIJS AEM, ET AL: Evaluation of myocardial viability using dual isotope simultaneous acquisition (DISA) with technetium-99m-tetrofosmin and 18-FDG and a three-head SPECT camera (abstract). J Nucl Med 1996; 37: 60P.
34. SANDLER MP, VIDELEFSKY S, DELBEKE D, ET AL: Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 870-888.
35. MARTIN WH, DELBEKE D, PATTON JA, ET AL: FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995; 36: 988-995.
36. KNUUTI J, NUUTILA P, RUOTSALAINEN U, ET AL: Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33: 1255-1262.
37. GROPLER RJ, SIEGEL BA, LEE KJ, ET AL: Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990; 31: 1749-1756.
38. KNUUTI MJ, YKI-JÄRVINEN H, VOIPIO-PULKKI LM, ET AL: Enhancement of myocardial [F-18]-FDG uptake by a nicotinic acid derivative. J Nucl Med 1994; 35: 989-998.
39. BAX JJ, VEENING MA, VISSER FC, ET AL: Optimal metabolic conditions during FDG imaging; a comparative study using different protocols. Eur J Nucl Med 1997; 24: 35-41.
40. BAX JJ, CORNEL JH, VISSER FC, FIORETTI PM, VISSER CA: Prediction of improvement of global function after revascularization in patients with ischemic left ventricular dysfunction; detection by F18-fluorodeoxyglucose SPECT (abstract). J Am Coll Cardiol 1997; 29: 377A-378A.
41. BAX JJ, CORNEL JH, VISSER FC, ET AL: Prediction of recovery of regional ventricular dysfunction following revascularization; comparison of F18-fluorodeoxyglucose SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28: 558-564.
42. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography. Eur Heart J 1997; 18: 941-948.